Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

Abstract excerpt

Background: Pathogenic germline mutations affecting the RET proto-oncogene underlie the development of hereditary medullary thyroid carcinoma (MTC). The aims of this study were to evaluate the prevalence of germline RET mutations in a large series of MTC, collected over the last 25 years, and to reappraise their clinical significance. Methods: We performed RET genetic screening in 2031 Italian subjects: patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroendocrine Tumor Research Advances
• Share to Neurofibromatosis and Schwannoma Cases
• Share to Thyroid Cancer Diagnosis and Treatment